Similar articles

• Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants.

  DeJonge M, Burchfield D, Bloom B, Duenas M, Walker W, Polak M, Jung E, Millard D, Schelonka R, Eyal F, Morris A, Kapik B, Roberson D, Kesler K, Patti J, Hetherington S. DeJonge M, et al. J Pediatr. 2007 Sep;151(3):260-5, 265.e1. doi: 10.1016/j.jpeds.2007.04.060. Epub 2007 Jul 24. J Pediatr. 2007. PMID: 17719934 Clinical Trial.
• Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates.

  Baker CJ, Melish ME, Hall RT, Casto DT, Vasan U, Givner LB. Baker CJ, et al. N Engl J Med. 1992 Jul 23;327(4):213-9. doi: 10.1056/NEJM199207233270401. N Engl J Med. 1992. PMID: 1614462 Clinical Trial.
• [Preventive antibiotic administration for prevention of nosocomial septicemia in very small premature infants (VLBW infants)--preventive vancomycin administration against infections with coagulase negative streptococci--prevention of translocation with oral cefixime therapy in intestinal colonization with pathogenic gram-negative pathogens].

  Möller JC, Rossa M, Nachtrodt G, Richter A, Tegtmeyer FK. Möller JC, et al. Klin Padiatr. 1993 May-Jun;205(3):140-4. doi: 10.1055/s-2007-1025215. Klin Padiatr. 1993. PMID: 8350584 Clinical Trial. German.
• Veronate (Inhibitex).

  Kaufman D. Kaufman D. Curr Opin Investig Drugs. 2006 Feb;7(2):172-9. Curr Opin Investig Drugs. 2006. PMID: 16499288 Review.
• Immunoenhancement to prevent nosocomial coagulase-negative staphylococcal sepsis in very low-birth-weight infants.

  Devlin LA, Lassiter HA. Devlin LA, et al. Clin Perinatol. 2004 Mar;31(1):69-75. doi: 10.1016/j.clp.2004.03.010. Clin Perinatol. 2004. PMID: 15183657 Review.